Entera Bio (ENTX) Other Gross PP&E Adjustments (2017 - 2025)
Entera Bio has reported Other Gross PP&E Adjustments over the past 9 years, most recently at -$465000.0 for Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments fell 69.09% year-over-year to -$465000.0, compared with a TTM value of -$465000.0 through Dec 2025, down 69.09%, and an annual FY2025 reading of -$465000.0, down 69.09% over the prior year.
- Other Gross PP&E Adjustments came in at -$465000.0 for Q4 2025, down from -$194000.0 in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$48000.0 in Q1 2023 to a low of -$465000.0 in Q4 2025.
- Median Other Gross PP&E Adjustments over the past 5 years was -$219500.0 (2022), compared with a mean of -$242250.0.
- The sharpest move saw Other Gross PP&E Adjustments soared 77.36% in 2023, then crashed 693.75% in 2024.
- Over 5 years, Other Gross PP&E Adjustments stood at -$239000.0 in 2021, then skyrocketed by 62.34% to -$90000.0 in 2022, then plummeted by 331.11% to -$388000.0 in 2023, then increased by 29.12% to -$275000.0 in 2024, then plummeted by 69.09% to -$465000.0 in 2025.
- Per Business Quant, the three most recent readings for ENTX's Other Gross PP&E Adjustments are -$465000.0 (Q4 2025), -$194000.0 (Q3 2025), and -$190000.0 (Q2 2025).